MODD News & Events

Modular Medical announced the start of production of validation lots for its Pivot tubeless patch pump's disposable cartridge and infusion set. Achievement of this manufacturing milestone keeps the Company on schedule for commercial launch in Q1 2026, subject to receipt of FDA 510(k) clearance. "We are excited to hit this pivotal manufacturing validation on schedule, bringing us closer to delivering our Pivot pump's game-changing simplicity to patients underserved by current options," said Jeb Besser, CEO. "This further derisks our expected path to Q1 2026 commercialization, which is subject to FDA response to our current 510(k) application, and would put us in position to drive market disruption."

Modular Medical announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. The shares of the common stock and the accompanying warrants are immediately separable and will be issued separately but can only be purchased together in this offering. Newbridge Securities Corporation is acting as the sole bookrunner for the proposed offering.